Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'm halfway expecting an announcement at the JP Morgan health conference in January. Of course, any such announcement would have to be preceded by data
Take a look at from this perspective. The market cap will not change with the switch to adrs. Should the company start producing revenue from any source the market cap will reflect the change whether it's denominated in either stock or adrs. Any improvement from current levels would be welcome and I frankly don't expect the share price to recover to the .50 range without an eua and given the complete and total focus of governments everywhere on shots to the exclusion of therapeutics that's not going to happen. A move up to 15 or 20 dollars per adr would be welcome.
My daughter graduated high school there. Where did you live
Del City right beside Tinker. I was stationed there.
I lived in OKC for 8 years on and off and there's no way you wouldn't know about ice. It came down in buckets on a routine basis shaped like a ball and sized anywhere from pea gravel to baseball. Usually in July and August.
From the last press release
The loan has a provision for prepayment, an annualized interest rate of 8% and OID of 10%. Upon announcement of the top line data ("TLD") from the Company's Phase III clinical trial of DCVax®-L for Glioblastoma brain cancer, the lender will have a then-springing right to exchange the outstanding balance of the loan for common shares priced at the price of the first private placement transaction following TLD less a 12% discount, and to purchase another 50% of that number of shares at the same price. This then-springing right expires 14 days after that post-TLD private placement.
Well that was an ass kicking.
News tonight?
I checked all my clothes pockets. I only came up with 76 cents.
JP Morgan Healthcare conference is in January. That has been a traditional venue for announcing big deals. With top line data out before the conference it's possible we'll see an announcement there.
I don't expect anything from this meeting tomorrow if it actually occurs. The press release today is classic JJ. Full of "news" that may or may not be true.
He hasn't had the goods yet. Everything he's done is aimed at stringing investors along. Don't put your hopes on anything he says.
Because they're not the same stock. They trade independently.
Ali. It's Ali, not Alli.
It has been posted and discussed. That's not our product.
It's not a big deal. If you look at the website you'll see it's just a listing of studies being carried out at the hospital. Dcvax is one of many.
Yep, so far. Not enough volume for capitulation and a sharp rebound from the low says bear raid.
Is it a bear raid or capitulation?
It's so obviously a photoshop it's not necessary to ask him the question.
Hear that? It's the sound of LP giving shorts a good whipping. Also know as the sound of one hand clapping.
Who's taking bets on the price action today?
It appears ex was the only one here who knew what he was talking about all along.
So, no sno today? Maybe some rain for our parade.
Ha! Good one
It appears the 1 dollar support level is in jeopardy. Can't wait for the next chart analysis predicting a breakout.
IkeEsq, my reply to your post was deleted. Hopefully you got to read it before it was removed.
Are you sure about that last paragraph? Most cases (read, the vast majority) resolve without even going to a hospital, especially among those who are younger and without comorbidities.
I assume this price decline means SNO is not happening for nwbo. As far as I know, those expectations were generated right here on this forum. Does anyone think this sort of hopium based speculation is counter productive?
At what point do we start to think the delay is because the data may be messy, as in they failed one or more of the secondary endpoints and are data mining to salvage something.
The nih trial goes until next October with data expected in 2023. Don't know about the other one. As for moving ahead with a new drug application, we'll it's JJ so I take that with a mountain of salt.
The question is, is it Oz or Ozymandias.
While that was highly entertaining, volume says it's not an indication of news. The open tomorrow might be interesting.
I did miss out. I'm at 1.48 average.
I will candidly admit that Linda Liau is the only reason I'm here. Nothing on this board or nothing released by the company sways me. Only LL.
Ah. Missed it.??
Charts don't work for stocks like this. Charting NWBO is a fanciful pastime that provides amusement for those so inclined but, basically worthless.
Your link doesn't work
Face palm
I view this as a once in a lifetime investment. Assuming results are good I don't plan to sell anything and if NWBO gets bought out I plan to take whatever shares I receive in the buyout and hold them. Of course, I'm prepared to lose what I have invested here if results aren't good but I don't think they will be.
Very little. Volume was nothing to write home about.
Lol. Their stock is down! There must be a pony around here somewhere.
It means there's a chance of meatballs.